Recent experimental and clinical studies have highlighted the crucial role of fibroblast growth factor 23 (FGF23) receptor, Vitamin D deficiency, systolic blood pressure in induction and progression of LVH in CKD patients [17–19]. This evidence concerns the gene FGF23 and vitamin D deficiency.